PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DAJ	Torkamani, A; Verkhivker, G; Schork, NJ				Torkamani, Ali; Verkhivker, Gennady; Schork, Nicholas J.			Cancer driver mutations in protein kinase genes	CANCER LETTERS			English	Review						Genomics; Single nucleotide polymorphisms; Protein structure; Tumorigenesis; Mutation	GROWTH-FACTOR RECEPTOR; CHRONIC MYELOGENOUS LEUKEMIA; ABL TYROSINE KINASE; C-MET INHIBITORS; CELL LUNG-CANCER; SOMATIC MUTATIONS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HUMAN BREAST; SEQUENCE-ANALYSIS	Recent studies investigating the genetic determinants of cancer suggest that some of the genetic alterations contributing to tumorigenesis may be inherited, but the vast majority is somatically acquired during the transition of a normal cell to a cancer cell. A systematic understanding of the genetic and molecular determinants of cancers has already begun to have a transformative effect on the study and treatment of cancer, particularly through the identification of a range of genetic alterations in protein kinase genes, which are highly associated with the disease. Since kinases are prominent therapeutic targets for intervention within the cancer cell, studying the impact that genomic alterations within them have on cancer initiation, progression, and treatment is both logical and timely. In fact, recent sequencing and resequencing (i.e., polymorphism identification) efforts have catalyzed the quest for protein kinase 'driver' mutations (i.e., those genetic alterations which contribute to the transformation of a normal cell to a proliferating cancerous cell) in distinction to kinase 'passenger' mutations which reflect mutations that merely build up in course of normal and unchecked (i.e., cancerous) somatic cell replication and proliferation. In this review, we discuss the recent progress in the discovery and functional characterization of protein kinase cancer driver mutations and the implications of this progress for understanding tumorigenesis as well as the design of 'personalized' cancer therapeutics that target an individual's unique mutational profile. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Torkamani, Ali; Schork, Nicholas J.] Scripps Hlth & Scripps Res Inst, Scripps Translat Sci Inst & Scripps Genom Med, La Jolla, CA 92037 USA; [Verkhivker, Gennady] Univ Kansas, Ctr Bioinformat, Sch Pharm, Lawrence, KS 66047 USA; [Verkhivker, Gennady] Univ Kansas, Dept Pharmaceut Chem, Sch Pharm, Lawrence, KS 66047 USA; [Verkhivker, Gennady] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Schork, NJ (reprint author), Scripps Hlth & Scripps Res Inst, Scripps Translat Sci Inst & Scripps Genom Med, 3344 N Torrey Pines Court,Suite 300,Room 306, La Jolla, CA 92037 USA.	nschork@scripps.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	NCRR NIH HHS [UL1 RR025774-02, UL1 RR025774]		Abu-Duhier FM, 2001, BRIT J HAEMATOL, V113, P983, DOI 10.1046/j.1365-2141.2001.02850.x; Albrecht BK, 2008, J MED CHEM, V51, P2879, DOI 10.1021/jm800043g; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Baselga J, 1998, CANCER RES, V58, P2825; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Cheetham GMT, 2007, CANCER LETT, V251, P323, DOI 10.1016/j.canlet.2006.12.004; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Chiara F, 2003, J BIOL CHEM, V278, P29352, DOI 10.1074/jbc.M302404200; Clarkson B, 2003, LEUKEMIA, V17, P1211, DOI 10.1038/sj.leu.2402912; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Cranston AN, 2006, CANCER RES, V66, P10179, DOI 10.1158/0008-5472.CAN-06-0884; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, EXPERT OPIN PHARMACO, V4, P963, DOI 10.1517/14656566.4.6.963; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Dussault I, 2008, CELL CYCLE, V7, P1157, DOI 10.4161/cc.7.9.5827; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Fang NY, 2003, P NATL ACAD SCI USA, V100, P5372, DOI 10.1073/pnas.0831102100; Ferrao PT, 2003, LEUKEMIA RES, V27, P547, DOI 10.1016/S0145-2126(02)00272-2; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garber K, 2005, J NATL CANCER I, V97, P1322, DOI 10.1093/jnci/dji324; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gujral TS, 2006, ANN NY ACAD SCI, V1073, P234, DOI 10.1196/annals.1353.025; Gujral TS, 2006, CANCER RES, V66, P10741, DOI 10.1158/0008-5472.CAN-06-3329; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANKS SK, 1995, FASEB J, V9, P576; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kaiser J, 2008, SCIENCE, V321, P26, DOI 10.1126/science.321.5885.26a; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kuhn P, 2002, CURR OPIN CHEM BIOL, V6, P704, DOI 10.1016/S1367-5931(02)00361-7; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lai AZ, 2007, ENDOCR PATHOL, V18, P57, DOI 10.1007/s12022-007-0009-5; Lander ES, 2000, SCIENCE, V287, P1777, DOI 10.1126/science.287.5459.1777; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lorenzato A, 2002, CANCER RES, V62, P7025; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Lydon NB, 2004, LEUKEMIA RES, V28, pS29, DOI 10.1016/j.leukres.2003.10.002; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Margulies EH, 2008, NAT REV GENET, V9, P303, DOI 10.1038/nrg2185; Maritano D, 2000, ONCOGENE, V19, P1354, DOI 10.1038/sj.onc.1203431; Menoyo A, 2001, CANCER RES, V61, P7727; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Minami Y, 2007, ONCOGENE, V26, P5023, DOI 10.1038/sj.onc.1210292; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Nakaigawa N, 2000, ONCOGENE, V19, P2996, DOI 10.1038/sj.onc.1203628; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Ortutay C, 2005, HUM MUTAT, V25, P435, DOI 10.1002/humu.20166; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; Park J, 2002, CANCER RES, V62, P1284; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; RENZO MFD, 2000, ONCOGENE, V19, P1547; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sawyer Tomi K., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P449, DOI 10.2174/1568011043352830; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1037/journal.pcbi.0010049; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sridhar R, 2000, PHARM RES-DORDR, V17, P1345, DOI 10.1023/A:1007507224529; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Strausberg RL, 2004, NATURE, V429, P469, DOI 10.1038/nature02627; Stredrick DL, 2006, HUM MUTAT, V27, P538, DOI 10.1002/humu.20323; Tan A, 2006, CLIN CHEM, V52, P2250, DOI 10.1373/clinchem.2006.068205; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; TYNER JW, 2008, HIGH THROUGHPUT MUTA; Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656; Verkhivker GM, 2007, PROTEINS, V66, P912, DOI 10.1002/prot.21287; Verkhivker GM, 2007, BIOINFORMATICS, V23, P1919, DOI 10.1093/bioinformatics/btm277; Verkhivker GM, 2006, BIOINFORMATICS, V22, P1846, DOI 10.1093/bioinformatics/btl199; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x	131	54	55	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3835	1872-7980		CANCER LETT	Cancer Lett.	AUG 28	2009	281	2					117	127		10.1016/j.canlet.2008.11.008				11	Oncology	Oncology	471RT	WOS:000268076700001	19081671	Green Accepted			2019-08-20	J	Pawlikowska, L; Hu, DL; Huntsman, S; Sung, A; Chu, C; Chen, J; Joyner, AH; Schork, NJ; Hsueh, WC; Reiner, AP; Psaty, BM; Atzmon, G; Barzilai, N; Cummings, SR; Browner, WS; Kwok, PY; Ziv, E				Pawlikowska, Ludmila; Hu, Donglei; Huntsman, Scott; Sung, Andrew; Chu, Catherine; Chen, Justin; Joyner, Alexander H.; Schork, Nicholas J.; Hsueh, Wen-Chi; Reiner, Alexander P.; Psaty, Bruce M.; Atzmon, Gil; Barzilai, Nir; Cummings, Steven R.; Browner, Warren S.; Kwok, Pui-Yan; Ziv, Elad		Study Osteoporotic Fractures	Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity	AGING CELL			English	Article						AKT1; FOXO3A; gene; IGF1; longevity; SNP	GENOME-WIDE ASSOCIATION; CAENORHABDITIS-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; EXCEPTIONAL LONGEVITY; HAPLOTYPE MAP; I RECEPTOR; C-ELEGANS; GENOTYPE; AGE	P>The insulin/IGF1 signaling pathways affect lifespan in several model organisms, including worms, flies and mice. To investigate whether common genetic variation in this pathway influences lifespan in humans, we genotyped 291 common variants in 30 genes encoding proteins in the insulin/IGF1 signaling pathway in a cohort of elderly Caucasian women selected from the Study of Osteoporotic Fractures (SOF). The cohort included 293 long-lived cases (lifespan >= 92 years (y), mean +/- standard deviation (SD) = 95.3 +/- 2.2y) and 603 average-lifespan controls (lifespan < 79y, mean = 75.7 +/- 2.6y). Variants were selected for genotyping using a haplotype-tagging approach. We found a modest excess of variants nominally associated with longevity. Nominally significant variants were then replicated in two additional Caucasian cohorts including both males and females: the Cardiovascular Health Study and Ashkenazi Jewish Centenarians. An intronic single nucleotide polymorphism in AKT1, rs3803304, was significantly associated with lifespan in a meta-analysis across the three cohorts (OR = 0.78 95%CI = 0.68-0.89, adjusted P = 0.043); two intronic single nucleotide polymorphisms in FOXO3A demonstrated a significant lifespan association among women only (rs1935949, OR = 1.35, 95%CI = 1.15-1.57, adjusted P = 0.0093). These results demonstrate that common variants in several genes in the insulin/IGF1 pathway are associated with human lifespan.	[Pawlikowska, Ludmila; Hsueh, Wen-Chi; Kwok, Pui-Yan; Ziv, Elad] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Hu, Donglei; Huntsman, Scott; Hsueh, Wen-Chi; Ziv, Elad] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Sung, Andrew; Chu, Catherine; Chen, Justin; Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Joyner, Alexander H.; Schork, Nicholas J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Joyner, Alexander H.; Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Reiner, Alexander P.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Reiner, Alexander P.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Reiner, Alexander P.; Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Ctr Hlth Studies, Seattle, WA USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Cummings, Steven R.; Browner, Warren S.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	Ziv, E (reprint author), 1701 Divisadero St,Suite 554,UCSF Box 1732, San Francisco, CA 94115 USA.	elad.ziv@ucsf.edu	Ziv, Elad/L-5396-2014; Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Chen, Justin/0000-0002-1661-4547	National Institute on Aging (NIA) [5U19AG023122, AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, 2 R01 AG027574-22A1]; National Heart, Lung, and Blood Institute [N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; National Institute of Neurological Disorders and Stroke	We acknowledge D. Lind for coordination of pilot studies, J. Atilano, S.-W. Chan, E. Lovins, and T.J. Nguyen for technical assistance and the staff of SOF and CHS Coordinating Centers for study support. This work was supported by the Longevity Consortium, http://www.longevityconsortium.org (National Institute on Aging (NIA) 5U19AG023122 to S.R.C. and W.S.B.). The SOF is supported by the NIA (AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, and 2 R01 AG027574-22A1). The CHS is supported by the National Heart, Lung, and Blood Institute (N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295) with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DORMAN JB, 1995, GENETICS, V141, P1399; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hsu Tony M, 2003, Methods Mol Biol, V212, P177; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kuningas M, 2008, AGING CELL, V7, P270, DOI 10.1111/j.1474-9726.2008.00366.x; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; LARSEN PL, 1995, GENETICS, V139, P1567; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okamoto H, 2003, J BIOL CHEM, V278, P28359, DOI 10.1074/jbc.R300009200; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tell G S, 1993, Ann Epidemiol, V3, P358; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	38	218	224	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9726			AGING CELL	Aging Cell	AUG	2009	8	4					460	472		10.1111/j.1474-9726.2009.00493.x				13	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	473NH	WOS:000268213300011	19489743	Green Accepted			2019-08-20	J	Wallace, DC; Fan, WW				Wallace, Douglas C.; Fan, WeiWei			The pathophysiology of mitochondrial disease as modeled in the mouse	GENES & DEVELOPMENT			English	Review						Mitochondrion; mtDNA; OXPHOS dysfunction; mitochondrial disease; mouse model	CYTOCHROME-C-OXIDASE; ADENINE-NUCLEOTIDE TRANSLOCATOR; HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; PERMEABILITY TRANSITION PORE; FOLLICLE-STIMULATING-HORMONE; DISMUTASE-DEFICIENT MICE; SUBSTANTIA-NIGRA NEURONS; DYNAMIN-RELATED PROTEIN; KEARNS-SAYRE SYNDROME	It is now clear that mitochondrial defects are associated with a plethora of clinical phenotypes in man and mouse. This is the result of the mitochondria's central role in energy production, reactive oxygen species (ROS) biology, and apoptosis, and because the mitochondrial genome consists of roughly 1500 genes distributed across the maternal mitochondrial DNA (mtDNA) and the Mendelian nuclear DNA (nDNA). While numerous pathogenic mutations in both mtDNA and nDNA mitochondrial genes have been identified in the past 21 years, the causal role of mitochondrial dysfunction in the common metabolic and degenerative diseases, cancer, and aging is still debated. However, the development of mice harboring mitochondrial gene mutations is permitting demonstration of the direct cause-and-effect relationship between mitochondrial dysfunction and disease. Mutations in nDNA-encoded mitochondrial genes involved in energy metabolism, antioxidant defenses, apoptosis via the mitochondrial permeability transition pore (mtPTP), mitochondrial fusion, and mtDNA biogenesis have already demonstrated the phenotypic importance of mitochondrial defects. These studies are being expanded by the recent development of procedures for introducing mtDNA mutations into the mouse. These studies are providing direct proof that mtDNA mutations are sufficient by themselves to generate major clinical phenotypes. As more different mtDNA types and mtDNA gene mutations are introduced into various mouse nDNA backgrounds, the potential functional role of mtDNA variation in permitting humans and mammals to adapt to different environments and in determining their predisposition to a wide array of diseases should be definitively demonstrated.	[Wallace, Douglas C.; Fan, WeiWei] Univ Calif Irvine, Org Res Unit Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	Wallace, DC (reprint author), Univ Calif Irvine, Org Res Unit Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.	dwallace@uci.edu	Fan, Weiwei/B-3782-2010		NIH [NS21328, AG24373, DK73691, AG13154, AG16573]; CIRM Comprehensive [RC1-00353-1]; Doris Duke Clinical Interfaces Award 2005	This work has been supported by NIH grants NS21328, AG24373, DK73691, AG13154, and AG16573; a CIRM Comprehensive Grant RC1-00353-1; a Doris Duke Clinical Interfaces Award 2005 awarded to D. C. W.; and a CIRM Predoctoral Fellowship awarded to W. F.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; AVISE JC, 1979, GENETICS, V92, P279; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BLANC H, 1981, P NATL ACAD SCI-BIOL, V78, P3789, DOI 10.1073/pnas.78.6.3789; BLANC H, 1981, NUCLEIC ACIDS RES, V9, P5785, DOI 10.1093/nar/9.21.5785; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brown MD, 1997, AM J HUM GENET, V60, P381; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; BROWN MD, 2002, J HUM GENET, V110, P130, DOI DOI 10.1007/S00439-001-0660-8; BUNN CL, 1977, SOMAT CELL GENET, V3, P71, DOI 10.1007/BF01550988; BUNN CL, 1974, P NATL ACAD SCI USA, V71, P1681, DOI 10.1073/pnas.71.5.1681; Cai JY, 2000, FREE RADICAL BIO MED, V29, P334, DOI 10.1016/S0891-5849(00)00312-9; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; De Benedictis G, 1999, FASEB J, V13, P1532; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; DiMauro S, 1993, MOL GENETIC BASIS NE, P665; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; FISHER RP, 1992, J BIOL CHEM, V267, P3358; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879; HOWELL N, 1988, J MOL BIOL, V203, P607, DOI 10.1016/0022-2836(88)90195-7; HOWELL N, 1990, BIOCHEMISTRY-US, V29, P8970, DOI 10.1021/bi00490a013; HOWELL N, 1987, J BIOL CHEM, V262, P2411; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602130013; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; KAPSA R, 1994, J INHERIT METAB DIS, V17, P521, DOI 10.1007/BF00711584; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J., 1995, American Journal of Human Genetics, V57, pA216; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; KHUSNUTDINOVA E, 2008, ANN NY ACAD IN PRESS; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; KOZAK LP, 1988, J BIOL CHEM, V263, P12274; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/3033; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Lott M.T., 2002, EMERY RIMOINS PRINCI, P299; LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; MacGregor GR, 2006, EMBRYONIC STEM CELLS, P72; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350; Murdock DG, 1999, J BIOL CHEM, V274, P14429, DOI 10.1074/jbc.274.20.14429; Nachman MW, 1996, GENETICS, V142, P953; Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004; Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65; Raby BA, 2007, J ALLERGY CLIN IMMUN, V120, P351, DOI 10.1016/j.jaci.2007.05.029; RADI R, 1991, J BIOL CHEM, V266, P22028; RADI R, 1993, FREE RADICAL BIO MED, V15, P653, DOI 10.1016/0891-5849(93)90169-U; RADI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P409, DOI 10.1006/abbi.1993.1055; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; REICHLING S, 1987, BIOCHEM BIOPH RES CO, V142, P696, DOI 10.1016/0006-291X(87)91470-7; RIDLEY RG, 1986, NUCLEIC ACIDS RES, V14, P4025, DOI 10.1093/nar/14.10.4025; Rodic N, 2005, STEM CELLS, V23, P1314, DOI 10.1634/stemcells.2005-0119; Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703; ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327; ROTIG A, 1988, LANCET, V2, P567; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sato A, 2007, GENETICS, V177, P2031, DOI 10.1534/genetics.107.081026; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Silva JP, 2000, NAT GENET, V26, P336; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SOONG NW, 1992, NAT GENET, V2, P318; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tanaka M, 2000, MECH AGEING DEV, V116, P65, DOI 10.1016/S0047-6374(00)00149-4; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Torroni A, 1997, AM J HUM GENET, V60, P1107; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trounce I, 2000, NUCLEIC ACIDS RES, V28, P2164, DOI 10.1093/nar/28.10.2164; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; WALLACE DC, 1977, SOMAT CELL GENET, V3, P93, DOI 10.1007/BF01550989; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; WALLACE DC, 1981, MOL CELL BIOL, V1, P697, DOI 10.1128/MCB.1.8.697; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; WALLACE DC, 1979, SOMAT CELL GENET, V5, P373, DOI 10.1007/BF01538849; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174; Wallace DC, 2007, EMERY RIMOINS PRINCI, P194; WALLACE DC, 2007, AM J HUM GENET; WALLACE DC, 2001, METABOLIC MOL BASES, P2425; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhu ZQ, 1998, NAT GENET, V20, P337; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	222	132	135	0	20	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369			GENE DEV	Genes Dev.	AUG	2009	23	15					1714	1736		10.1101/gad.1784909				23	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	478OW	WOS:000268598600004	19651984	Green Published, Bronze			2019-08-20	J	Cresci, S; Kelly, RJ; Cappola, TP; Diwan, A; Dries, D; Kardia, SLR; Dorn, GW				Cresci, Sharon; Kelly, Reagan J.; Cappola, Thomas P.; Diwan, Abhinav; Dries, Daniel; Kardia, Sharon L. R.; Dorn, Gerald W., II			Clinical and Genetic Modifiers of Long-Term Survival in Heart Failure	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY			English	Article						heart failure; beta-blocker; gene polymorphism; beta adrenergic receptor; G-protein receptor kinase	LEFT-VENTRICULAR DYSFUNCTION; COUPLED RECEPTOR KINASES; BETA-BLOCKER THERAPY; BETA(1)-ADRENERGIC RECEPTOR; MERIT-HF; DILATED CARDIOMYOPATHY; POLYMORPHISMS; ASSOCIATION; CARVEDILOL; DISEASE	Objectives This study sought to identify genetic modifiers of beta-blocker response and long-term survival in heart failure (HF). Background Differences in beta-blocker treatment effect between Caucasians and African Americans with HF have been reported. Methods This was a prospective cohort study of 2,460 patients (711 African American, 1,749 Caucasian) enrolled between 1999 and 2007; 2,039 patients (81.7%) were treated with a beta-blocker. Each was genotyped for beta 1-adrenergic receptor (ADRB1) Arg389>Gly and G-protein receptor kinase 5 (GRK5) Gln41>Leu polymorphisms, which are more prevalent among African Americans than Caucasians. The primary end point was survival time from HF onset. Results There were 765 deaths during follow-up (median 46 months). beta-blocker treatment increased survival in Caucasians (log-rank p = 0.00038) but not African Americans (log-rank p = 0.327). Among patients not taking beta-blockers, ADRB1 Gly389 was associated with decreased survival in Caucasians (hazard ratio [HR]: 1.98, 95% confidence interval [CI]: 1.1 to 3.7, p = 0.03) whereas GRK5 Leu41 was associated with improved survival in African Americans (HR: 0.325, CI: 0.133 to 0.796, p = 0.01). African Americans with ADRB1 Gly389Gly GRK5 Gln41Gln derived a similar survival benefit from beta-blocker therapy (HR: 0.385, 95% CI: 0.182 to 0.813, p = 0.012) as Caucasians with the same genotype (HR: 0.529, 95% CI: 0.326 to 0.858, p = 0.0098). Conclusions These data show that differences caused by beta-adrenergic receptor signaling pathway gene polymorphisms, rather than race, are the major factors contributing to apparent differences in the beta-blocker treatment effect between Caucasians and African Americans; proper evaluation of treatment response should account for genetic variance. (J Am Coll Cardiol 2009; 54:432-44) (C) 2009 by the American College of Cardiology Foundation	[Cresci, Sharon; Diwan, Abhinav; Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, Dept Med, Sch Med, St Louis, MO 63110 USA; [Kelly, Reagan J.; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Cappola, Thomas P.; Dries, Daniel] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA	Dorn, GW (reprint author), Washington Univ, Ctr Pharmacogenom, Dept Med, Sch Med, 660 S Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu			NCRR NIH HHS [UL1 RR024992]; NCATS NIH HHS [UL1 TR000448]; NHLBI NIH HHS [R01 HL080008-03, P50 HL077101-010002, R01 HL080008-04, R01 HL059888-10, R01 HL059888-05, R01 HL080008-01A1, P50 HL077101, P50 HL077113, R01 HL059888-06, R01 HL080008, R01 HL059888-04, P50 HL077101-019001, R01 HL087871-03, R01 HL088577, R01 HL080008-02, R01 HL059888-09A1, R01 HL087871, R01 HL059888-08, R01 HL087871-04, P50 HL077101-01, R01 HL059888-03, R01 HL087871-02, R01 HL059888-01A1, R01 HL059888-02, R01 HL059888-07, R01 HL087871-01, R01 HL059888]		Akhter SA, 2006, AM J PHYSIOL-HEART C, V290, pH1427, DOI 10.1152/ajpheart.00908.2005; American Heart Association, 2001, 2002 HEART STROK STA; Biolo A, 2008, AM J CARDIOL, V102, P726, DOI 10.1016/j.amjcard.2008.04.070; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRISTOW MR, 1993, J AM COLL CARDIOL, V22, P61; Brodde OE, 2008, PHARMACOL THERAPEUT, V117, P1, DOI 10.1016/j.pharmthera.2007.07.002; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Chen L, 2007, PHARMACOGENET GENOM, V17, P941, DOI 10.1097/FPC.0b013e3282ef7354; de Groote P, 2005, PHARMACOGENET GENOM, V15, P137, DOI 10.1097/01213011-200503000-00001; Deo RC, 2007, PLOS GENET, V3, P2200, DOI 10.1371/journal.pgen.0030196; DIAZ RA, 1987, BRIT HEART J, V58, P393; Domanski MJ, 2003, J CARD FAIL, V9, P354, DOI 10.1054/S1071-9164(03)00133-7; Dorn GW, 2008, CTS-CLIN TRANSL SCI, V1, P255, DOI 10.1111/j.1752-8062.2008.00059.x; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Gillum RF, 1996, NEW ENGL J MED, V335, P1597, DOI 10.1056/NEJM199611213352110; GILLUM RF, 1987, AM HEART J, V113, P1043, DOI 10.1016/0002-8703(87)90077-9; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hall W. Dallas, 1999, Ethnicity and Disease, V9, P333; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hjalmarson A, 1999, LANCET, V353, P2001; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Kaye DM, 2004, J AM COLL CARDIOL, V44, P2008, DOI 10.1016/j.jacc.2004.07.058; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kurnik D, 2008, PHARMACOGENET GENOM, V18, P895, DOI 10.1097/FPC.0b013e328309733f; Leak TS, 2007, MOL GENET METAB, V92, P145, DOI 10.1016/j.ymgme.2007.05.014; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Marsh S, 2005, METH MOL B, V311, P97; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Mehlotra RK, 2007, BRIT J CLIN PHARMACO, V64, P391, DOI 10.1111/j.1365-2125.2007.02884.x; MIALET PJ, 2003, NAT MED, V9, P1300, DOI DOI 10.1038/NM930; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Pacanowski MA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-11; Pamboukian SV, 2003, J CARD FAIL, V9, P80, DOI 10.1054/jcaf.2003.11; Parmar MKB, 1995, SURVIVAL ANAL PRACTI; Patin E, 2006, AM J HUM GENET, V78, P423, DOI 10.1086/500614; Podlowski S, 2000, J MOL MED-JMM, V78, P87, DOI 10.1007/s001090000080; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; R Development Core Team, 2008, LANG ENV STAT COMP; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rozen S, 2000, Methods Mol Biol, V132, P365; Sehnert AJ, 2008, J AM COLL CARDIOL, V52, P644, DOI 10.1016/j.jacc.2008.05.022; Smedley BD, 2002, UNEQUAL TREATMENT CO; Terra Steven G, 2005, Pharmacogenet Genomics, V15, P227, DOI 10.1097/01213011-200504000-00006; Wang WCH, 2008, PHARMACOGENET GENOM, V18, P729, DOI 10.1097/FPC.0b013e32830967e9; White HL, 2003, EUR J HEART FAIL, V5, P463, DOI 10.1016/S1388-9842(03)00044-8; Yancy Clyde W, 2007, MedGenMed, V9, P28; Yancy Clyde W, 2004, Congest Heart Fail, V10, P15, DOI 10.1111/j.1527-5299.2004.02026.x; Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803; Yancy CW, 2000, J CARD FAIL, V6, P183, DOI 10.1054/jcaf.2000.17610; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zhu XF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001244	58	65	67	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0735-1097	1558-3597		J AM COLL CARDIOL	J. Am. Coll. Cardiol.	JUL 28	2009	54	5					432	444		10.1016/j.jacc.2009.05.009				13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	475BG	WOS:000268329900009	19628119	Bronze, Green Accepted			2019-08-20	J	Erqou, S; Kaptoge, S; Perry, PL; Di Angelantonio, E; Thompson, A; White, IR; Marcovina, SM; Collins, R; Thompson, SG; Danesh, J				Erqou, Sebhat; Kaptoge, Stephen; Perry, Philip L.; Di Angelantonio, Emanuele; Thompson, Alexander; White, Ian R.; Marcovina, Santica M.; Collins, Rory; Thompson, Simon G.; Danesh, John		Emerging Risk Factors Collaboratio	Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MIDDLE-AGED MEN; NESTED CASE-CONTROL; ACUTE MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-A-I; 10-YEAR FOLLOW-UP; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; PLASMA LIPOPROTEIN(A); ELEVATED LIPOPROTEIN(A); OXIDIZED PHOSPHOLIPIDS	Context Circulating concentration of lipoprotein(a) (Lp[a]), a large glycoprotein attached to a low-density lipoprotein-like particle, may be associated with risk of coronary heart disease (CHD) and stroke. Objective To assess the relationship of Lp(a) concentration with risk of major vascular and nonvascular outcomes. Study Selection Long-term prospective studies that recorded Lp(a) concentration and subsequent major vascular morbidity and/or cause-specific mortality published between January 1970 and March 2009 were identified through electronic searches of MEDLINE and other databases, manual searches of reference lists, and discussion with collaborators. Data Extraction Individual records were provided for each of 126 634 participants in 36 prospective studies. During 1.3 million person-years of follow-up, 22 076 first-ever fatal or nonfatal vascular disease outcomes or nonvascular deaths were recorded, including 9336 CHD outcomes, 1903 ischemic strokes, 338 hemorrhagic strokes, 751 unclassified strokes, 1091 other vascular deaths, 8114 nonvascular deaths, and 242 deaths of unknown cause. Within-study regression analyses were adjusted for within-person variation and combined using meta-analysis. Analyses excluded participants with known preexisting CHD or stroke at baseline. Data Synthesis Lipoprotein(a) concentration was weakly correlated with several conventional vascular risk factors and it was highly consistent within individuals over several years. Associations of Lp(a) with CHD risk were broadly continuous in shape. In the 24 cohort studies, the rates of CHD in the top and bottom thirds of baseline Lp(a) distributions, respectively, were 5.6 (95% confidence interval [CI], 5.4-5.9) per 1000 person-years and 4.4 (95% CI, 4.2-4.6) per 1000 person-years. The risk ratio for CHD, adjusted for age and sex only, was 1.16 (95% CI, 1.11-1.22) per 3.5-fold higher usual Lp(a) concentration (ie, per 1 SD), and it was 1.13 (95% CI, 1.09-1.18) following further adjustment for lipids and other conventional risk factors. The corresponding adjusted risk ratios were 1.10 (95% CI, 1.02-1.18) for ischemic stroke, 1.01 (95% CI, 0.981.05) for the aggregate of nonvascular mortality, 1.00 (95% CI, 0.97-1.04) for cancer deaths, and 1.00 (95% CI, 0.95-1.06) for nonvascular deaths other than cancer. Conclusion Under a wide range of circumstances, there are continuous, independent, and modest associations of Lp(a) concentration with risk of CHD and stroke that appear exclusive to vascular outcomes. JAMA. 2009;302(4):412-423	[Danesh, John] Univ Cambridge, Emerging Risk Factors Collaborat Coordinating Ctr, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [White, Ian R.; Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Marcovina, Santica M.] Univ Washington, Seattle, WA 98195 USA; [Collins, Rory] Univ Oxford, Oxford, England	Danesh, J (reprint author), Univ Cambridge, Emerging Risk Factors Collaborat Coordinating Ctr, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Meisinger, Christine/B-5358-2014; Brunner, Eric/H-2114-2011; vhmpp, aks/F-9756-2012; Thompson, Alexander/A-6109-2010; Breteler, Monique M.B./J-5058-2014; Dankner, Rachel/Q-5245-2019; Gudnason, Vilmundur/K-6885-2015; de la Camara, Agustin Gomez/S-7123-2018; Ferrieres, Jean/S-7993-2016; Davey Smith, George/A-7407-2013; Sundstrom, Johan/A-6286-2009	Brunner, Eric/0000-0002-0595-4474; Breteler, Monique M.B./0000-0002-0626-9305; Dankner, Rachel/0000-0001-6454-6000; Gudnason, Vilmundur/0000-0001-5696-0084; Rothenbacher, Dietrich/0000-0002-3563-2791; Jorgensen, Torben/0000-0001-9453-2830; Ulmer, Hanno/0000-0001-5911-1002; Lochen, Maja-Lisa/0000-0002-8532-6573; Ferrieres, Jean/0000-0001-6144-1297; s, hema/0000-0002-3440-9475; Marmot, Michael/0000-0002-2431-6419; Morris, Richard/0000-0001-7240-4563; Davey Smith, George/0000-0002-1407-8314; Jespersen, Jorgen/0000-0002-3059-2356; Ramachandran, Vasan/0000-0001-7357-5970; Lawlor, Debbie A/0000-0002-6793-2262; Di Angelantonio, Emanuele/0000-0001-8776-6719; Lamarche, Benoit/0000-0002-4443-5378; Sundstrom, Johan/0000-0003-2247-8454; Amouyel, Philippe/0000-0001-9088-234X; Engstrom, Gunnar/0000-0002-8618-9152; Chen, Zhengming/0000-0001-6423-105X; Bladbjerg, Else Marie/0000-0003-0912-2437	British Heart Foundation [RG/08/014]; UK Medical Research Council; BUPA Foundation; GlaxoSmithKline; Merck Sharp and Dohme; Gates Cambridge Trust; Overseas Studentship Award	ERFC Coordinating Centre is supported by a program grant from the British Heart Foundation (RG/08/014) and supported by grants from the UK Medical Research Council and the BUPA Foundation. Aspects of this work have been supported by unrestricted educational grants from GlaxoSmithKline and a grant from Merck Sharp and Dohme in relation to Lp(a). A variety of sources have supported recruitment, follow-up, and laboratory measurements in the 116 cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list naming some of these funding sources, available at http://www.phpc.cam.ac.uk/MEU/.Dr Erqou is supported by a Gates Cambridge Trust and Overseas Studentship Award. Drs Di Angelantonio and Thompson have been supported by UK Medical Research Council PhD studentships.	ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Andresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222; Anuurad E, 2006, CLIN LAB MED, V26, P751, DOI 10.1016/j.cll.2006.07.002; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Barlera S, 2007, EUR J HUM GENET, V15, P221, DOI 10.1038/sj.ejhg.5201732; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berg K, 1997, CLIN GENET, V52, P254; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Boomsma D I, 2000, Twin Res, V3, P152, DOI 10.1375/twin.3.3.152; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; Braeckman L, 1996, EUR HEART J, V17, P1808; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLEMAN MP, 1992, ATHEROSCLEROSIS, V92, P177, DOI 10.1016/0021-9150(92)90276-M; Craig WY, 1998, CLIN CHEM, V44, P2301; Cremer P, 1997, ATHEROSCLEROSIS, V129, P221, DOI 10.1016/S0021-9150(96)06030-3; D'Angelo A, 2006, HAEMATOL-HEMATOL J, V91, P1613; Dahlen G, 1988, Arctic Med Res, V47 Suppl 1, P458; DAHLEN G, 1972, ACTA MED SCAND, P1; Dahlen GH, 1998, J INTERN MED, V244, P425; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI [10.1007/s10654-006-9096-8, 10.1007/s10654-007-9165-7]; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363; Dati F, 2004, CLIN CHEM LAB MED, V42, P670, DOI 10.1515/CCLM.2004.114; Downs JR, 1997, AM J CARDIOL, V80, P287, DOI 10.1016/S0002-9149(97)00347-0; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Evans RW, 2001, J CLIN EPIDEMIOL, V54, P51, DOI 10.1016/S0895-4356(00)00260-2; Gardner CD, 2000, AM J CARDIOL, V86, P299, DOI 10.1016/S0002-9149(00)00918-8; Gaw A, 2005, ATHEROSCLEROSIS, V180, P381, DOI 10.1016/j.atherosclerosis.2004.12.015; Gaw A, 2000, ATHEROSCLEROSIS, V148, P95, DOI 10.1016/S0021-9150(99)00259-2; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Ingelsson E, 2005, J AM COLL CARDIOL, V46, P2054, DOI 10.1016/j.jacc.2005.07.059; Insull W, 2004, ARCH INTERN MED, V164, P1121, DOI 10.1001/archinte.164.10.1121; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; KEIL JE, 1984, AM HEART J, V108, P779, DOI 10.1016/0002-8703(84)90671-9; Kiechl S, 2007, ARTERIOSCL THROM VAS, V27, P1788, DOI 10.1161/ATVBAHA.107.145805; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5; KOSTNER GM, 1989, CIRCULATION, V80, P1313, DOI 10.1161/01.CIR.80.5.1313; Kostner Karam M, 2004, Semin Vasc Med, V4, P211, DOI 10.1055/s-2004-835380; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Lakka HM, 2000, ARCH INTERN MED, V160, P1160, DOI 10.1001/archinte.160.8.1160; Lubin F, 1998, NUTR CANCER, V30, P78, DOI 10.1080/01635589809514645; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; MAHER VMG, 1995, JAMA-J AM MED ASSOC, V274, P1771, DOI 10.1001/jama.274.22.1771; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Marcovina SM, 2000, CLIN CHEM, V46, P1956; Marcovina SM, 1998, AM J CARDIOL, V82, p57U, DOI 10.1016/S0002-9149(98)00954-0; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Merki E, 2008, CIRCULATION, V118, P743, DOI 10.1161/CIRCULATIONAHA.108.786822; Mooser V, 1997, AM J HUM GENET, V61, P402, DOI 10.1086/514851; Nguyen TT, 1997, CIRCULATION, V96, P1390, DOI 10.1161/01.CIR.96.5.1390; Nielsen LB, 1997, ARTERIOSCL THROM VAS, V17, P905, DOI 10.1161/01.ATV.17.5.905; Nielsen LB, 1998, ARTERIOSCL THROM VAS, V18, P641, DOI 10.1161/01.ATV.18.4.641; Onat A, 2001, ATHEROSCLEROSIS, V156, P1, DOI 10.1016/S0021-9150(01)00500-7; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Paultre F, 2000, ARTERIOSCL THROM VAS, V20, P2619, DOI 10.1161/01.ATV.20.12.2619; Pitsavos C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-32; Poon M, 1997, CIRCULATION, V96, P2514, DOI 10.1161/01.CIR.96.8.2514; Price JF, 2001, ATHEROSCLEROSIS, V157, P241, DOI 10.1016/S0021-9150(00)00719-X; Rajecki M, 2005, BLOOD COAGUL FIBRIN, V16, P119, DOI 10.1097/01.mbc.0000161565.74387.5b; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Seed M, 2001, AM J MED, V110, P22, DOI 10.1016/S0002-9343(00)00652-5; Shai I, 2005, EUR HEART J, V26, P1633, DOI 10.1093/eurheartj/ehi222; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Simons LA, 2002, AM J CARDIOL, V89, P69, DOI 10.1016/S0002-9149(01)02168-3; Smolders B, 2007, STROKE, V38, P1959, DOI 10.1161/STROKEAHA.106.480657; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; Tate JR, 1998, CLIN CHEM, V44, P1629; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Tsimikas S, 2007, ARTERIOSCL THROM VAS, V27, P2094, DOI 10.1161/01.atv.0000280571.28102.d4; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Wang WY, 2002, ANN EPIDEMIOL, V12, P107, DOI 10.1016/S1047-2797(01)00273-3; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; TREATMENT HDL REDUCE	101	687	714	4	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 22	2009	302	4					412	423						12	Medicine, General & Internal	General & Internal Medicine	472NQ	WOS:000268139200024	19622820	Green Accepted, Green Published	Y	N	2019-08-20	J	Dai, DF; Santana, LF; Vermulst, M; Tomazela, DM; Emond, MJ; MacCoss, MJ; Gollahon, K; Martin, GM; Loeb, LA; Ladiges, WC; Rabinovitch, PS				Dai, Dao-Fu; Santana, Luis F.; Vermulst, Marc; Tomazela, Daniela M.; Emond, Mary J.; MacCoss, Michael J.; Gollahon, Katherine; Martin, George M.; Loeb, Lawrence A.; Ladiges, Warren C.; Rabinovitch, Peter S.			Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging	CIRCULATION			English	Article						aging; diastole; mitochondria; oxidant stress; survival	CARDIOVASCULAR-DISEASE ENTERPRISES; MAJOR SHAREHOLDERS; LIFE-SPAN; PART II; MICE; DYSFUNCTION; HEART; CARDIOMYOCYTE; HYPERTROPHY; MECHANISMS	Background-Age is a major risk for cardiovascular diseases. Although mitochondrial reactive oxygen species have been proposed as one of the causes of aging, their role in cardiac aging remains unclear. We have previously shown that overexpression of catalase targeted to mitochondria (mCAT) prolongs murine median lifespan by 17% to 21%. Methods and Results-We used echocardiography to study cardiac function in aging cohorts of wild-type and mCAT mice. Changes found in wild-type mice recapitulate human aging: age-dependent increases in left ventricular mass index and left atrial dimension, worsening of the myocardial performance index, and a decline in diastolic function. Cardiac aging in mice is accompanied by accumulation of mitochondrial protein oxidation, increased mitochondrial DNA mutations and deletions and mitochondrial biogenesis, increased ventricular fibrosis, enlarged myocardial fiber size, decreased cardiac SERCA2 protein, and activation of the calcineurin-nuclear factor of activated T-cell pathway. All of these age-related changes were significantly attenuated in mCAT mice. Analysis of survival of 130 mice demonstrated that echocardiographic cardiac aging risk scores were significant predictors of mortality. The estimated attributable risk to mortality for these 2 parameters was 55%. Conclusions-This study shows that cardiac aging in the mouse closely recapitulates human aging and demonstrates the critical role of mitochondrial reactive oxygen species in cardiac aging and the impact of cardiac aging on survival. These findings also support the potential application of mitochondrial antioxidants in reactive oxygen species-related cardiovascular diseases. (Circulation. 2009; 119:2789-2797.)	[Dai, Dao-Fu; Vermulst, Marc; Gollahon, Katherine; Martin, George M.; Loeb, Lawrence A.; Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Santana, Luis F.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Tomazela, Daniela M.; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Emond, Mary J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Rabinovitch, PS (reprint author), Univ Washington, Dept Pathol, 1959 Pacific Ave NE,HSB-K081, Seattle, WA 98195 USA.	petersr@u.washington.edu		Santana, Luis/0000-0002-4297-8029; Dai, Dao-Fu/0000-0001-7724-321X	National Institutes of Health [P30 AG013280, P01 AG001751]	This work was supported by National Institutes of Health grants P30 AG013280 and P01 AG001751.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Basso N, 2007, AM J PHYSIOL-HEART C, V293, pH1351, DOI 10.1152/ajpheart.00393.2007; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; Butler RN, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a399; Date M, 2002, J AM COLL CARDIOL, V39, P907, DOI 10.1016/S0735-1097(01)01826-5; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Etches V, 2006, ANNU REV PUBL HEALTH, V27, P29, DOI 10.1146/annurev.publhealth.27.021405.102141; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Houser SR, 2000, J MOL CELL CARDIOL, V32, P1595, DOI 10.1006/jmcc.2000.1206; INSERRA F, 1995, HYPERTENSION, V25, P437, DOI 10.1161/01.HYP.25.3.437; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Lim CC, 2000, J MOL CELL CARDIOL, V32, P2075, DOI 10.1006/jmcc.2000.1239; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Murphy Sean W., 2004, Curr Treat Options Cardiovasc Med, V6, P61, DOI 10.1007/s11936-004-0015-6; Ren J, 2007, MECH AGEING DEV, V128, P276, DOI 10.1016/j.mad.2006.12.007; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Song LS, 2002, CIRC RES, V90, P174, DOI 10.1161/hh0202.103230; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tei C, 1995, J Cardiol, V26, P357; Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	33	253	260	3	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7322	1524-4539		CIRCULATION	Circulation	JUN 2	2009	119	21					2789	U79		10.1161/CIRCULATIONAHA.108.822403				25	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	452DY	WOS:000266521400007	19451351	Bronze, Green Accepted	Y	N	2019-08-20	J	Caulfield, MJ; Bochud, M				Caulfield, M. J.; Bochud, M.		Global BP Gen	EIGHT BLOOD PRESSURE LOCI IDENTIFIED BY A GENOME-WIDE ASSOCIATION STUDY OF 34,433 PEOPLE OF EUROPEAN ANCESTRY	JOURNAL OF HYPERTENSION			English	Meeting Abstract	19th European Meeting on Hypertension	JUN 12-16, 2009	Milan, ITALY						[Caulfield, M. J.] Barts & London Queen Marys Sch Med & Dent, London, England; [Bochud, M.] Univ Lausanne, CHU Vaudois, Lausanne, Switzerland			Bochud, Murielle/A-3981-2010	Bochud, Murielle/0000-0002-5727-0218				0	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352			J HYPERTENS	J. Hypertens.	JUN	2009	27						S167	S167						1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	489SU	WOS:000269443600578					2019-08-20	J	Hahn, ME; Allan, LL; Sherr, DH				Hahn, Mark E.; Allan, Lenka L.; Sherr, David H.			Regulation of constitutive and inducible AHR signaling: Complex interactions involving the AHR repressor	BIOCHEMICAL PHARMACOLOGY			English	Review						Aryl hydrocarbon receptor; Aryl hydrocarbon receptor repressor; PAS proteins; Cancer; Toxicology	ARYL-HYDROCARBON RECEPTOR; MAMMARY-TUMOR CELL; POLYCYCLIC AROMATIC-HYDROCARBONS; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; DIOXIN RECEPTOR; BREAST-CANCER; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; PRO185ALA POLYMORPHISM	The AHR is well known for regulating responses to an array of environmental chemicals. A growing body of evidence supports the hypothesis that the AHR also plays perhaps an even more important role in modulating critical aspects of cell function including cell growth, death, and migration. As these and other important AHR activities continue to be elucidated, it becomes apparent that attention now must be directed towards the mechanisms through which the AHR itself is regulated. Here, we review what is known of and what biological outcomes have been attributed to the AHR repressor (AHRR), an evolutionarily conserved bHLH-PAS protein that inhibits both xenobiotic-induced and constitutively active AHR transcriptional activity in multiple species. We discuss the structure and evolution of the AHRR and the dominant paradigm of a xenobiotic-inducible negative feedback loop comprised of AHR-mediated transcriptional up-regulation of AHRR and the subsequent AHRR-mediated suppression of AHR activity. We highlight the role of the AHRR in limiting AHR activity in the absence of xenobictic AHR ligands and the important contribution of constitutively repressive AHRR to cancer biology. in this context, we also suggest a new hypothesis proposing that, under some circumstances, constitutively active AHR may repress AHRR transcription, resulting in unbridled AHR activity. We also review the predominant hypotheses on the molecular mechanisms through which AHRR inhibits AHR as well as novel mechanisms through which the AHRR may exert AHR-independent effects. Collectively, this discussion emphasizes the importance of this understudied bHLH-PAS protein in tissue development, normal cell biology, xenobiotic responsiveness, and AHR-regulated malignancy. (C) 2008 Elsevier Inc. All rights reserved.	[Allan, Lenka L.; Sherr, David H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Sherr, DH (reprint author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, 715 Albany St,R-408, Boston, MA 02118 USA.	dsherr@bu.edu		Sherr, David/0000-0003-3353-0553; Hahn, Mark/0000-0003-4358-2082	NIEHS NIH HHS [P01-ES11624, P42 ES007381-040004, P42 ES007381-050004, P42 ES007381, R01 ES006272, P01 ES011624, P01 ES011624-020001, R01 ES006272-13]		Abdelrahim M, 2003, MOL PHARMACOL, V63, P1373, DOI 10.1124/mol.63.6.1373; Allan LL, 2005, MOL PHARMACOL, V67, P1740, DOI 10.1124/mol.104.009100; Aragon AC, 2008, TOXICOL SCI, V101, P321, DOI 10.1093/toxsci/kfm272; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Bernshausen T, 2006, ARCH TOXICOL, V80, P206, DOI 10.1007/s00204-005-0025-5; Caruso JA, 2006, J BIOL CHEM, V281, P10954, DOI 10.1074/jbc.M508383200; Cauchi S, 2003, PHARMACOGENETICS, V13, P339, DOI 10.1097/01.fpc.0000054093.48725.79; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Duan RQ, 1999, MOL ENDOCRINOL, V13, P1511, DOI 10.1210/me.13.9.1511; Elizondo G, 2000, MOL PHARMACOL, V57, P1056; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; EVANS BR, 2006, TOXICOL SCI S, V84, P278; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Fujita H, 2002, TERATOLOGY, V65, P10, DOI 10.1002/tera.1093; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Gradin K, 1999, J BIOL CHEM, V274, P13511, DOI 10.1074/jbc.274.19.13511; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007; HAUBEN E, 2008, BLOOD; Hockings JK, 2006, CANCER RES, V66, P2224, DOI 10.1158/0008-5472.CAN-05-1619; Hosoya T, 2008, BIOCHEM BIOPH RES CO, V365, P562, DOI 10.1016/j.bbrc.2007.11.016; Huang GM, 2005, MOL PHARMACOL, V67, P88, DOI 10.1124/mol.104.002410; Hurst CH, 2002, TOXICOL SCI, V65, P87, DOI 10.1093/toxsci/65.1.87; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Ito T, 2004, J BIOL CHEM, V279, P25204, DOI 10.1074/jbc.M402143200; Jeffy BD, 2002, ENVIRON MOL MUTAGEN, V39, P235, DOI 10.1002/em.10051; JENNY MJ, 2008, TOXICOL SCI S, V102, P452; Kanno Y, 2008, MOL CELL ENDOCRINOL, V291, P87, DOI 10.1016/j.mce.2008.05.004; Kanno Y, 2006, BIOL PHARM BULL, V29, P1254, DOI 10.1248/bpb.29.1254; Kanno Y, 2007, BIOCHEM BIOPH RES CO, V364, P1026, DOI 10.1016/j.bbrc.2007.10.140; Karchner SI, 2002, J BIOL CHEM, V277, P6949, DOI 10.1074/jbc.M110779200; KARCHNER SI, 2007, TOXICOL SCI S, V96, P190; KARCHNER SI, 2008, TOXICOL SCI S, V102, P451; Kawajiri K, 2007, ARCH BIOCHEM BIOPHYS, V464, P207, DOI 10.1016/j.abb.2007.03.038; Keen JC, 2003, CANCER-AM CANCER SOC, V97, P825, DOI 10.1002/cncr.11126; Kikuchi Y, 2003, J BIOCHEM, V134, P83, DOI 10.1093/jb/mvg115; Kim SH, 2007, HUM REPROD, V22, P1866, DOI 10.1093/humrep/dem112; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Korkalainen M, 2005, TOXICOLOGY, V208, P1, DOI 10.1016/j.tox.2004.11.003; Korkalainen M, 2004, BIOCHEM BIOPH RES CO, V315, P123, DOI 10.1016/j.bbrc.2004.01.028; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Levine-Fridman A, 2004, MOL PHARMACOL, V65, P461, DOI 10.1124/mol.65.2.461; Liu CQ, 2003, J BIOL CHEM, V278, P44857, DOI 10.1074/jbc.M304489200; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Marlowe JL, 2004, J BIOL CHEM, V279, P29013, DOI 10.1074/jbc.M404315200; Marshall NB, 2008, J IMMUNOL, V181, P2382, DOI 10.4049/jimmunol.181.4.2382; MATIKAINEN T, 2001, NAT GENET, V28, P1; Matikainen TM, 2002, ENDOCRINOLOGY, V143, P615, DOI 10.1210/en.143.2.615; Merisalu A, 2007, FERTIL STERIL, V88, P854, DOI 10.1016/j.fertnstert.2006.12.041; Miller ME, 2005, CLIN EXP METASTAS, V22, P149, DOI 10.1007/s10585-005-6536-x; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; MURRAY SA, 2005, J CELL BIOCH; Murray TJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1391; Nagase T, 2000, DNA RES, V7, P273; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nishihashi H, 2006, BIOL PHARM BULL, V29, P640, DOI 10.1248/bpb.29.640; Oenga GN, 2004, TOXICOL IN VITRO, V18, P811, DOI 10.1016/j.tiv.2004.04.004; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Oshima M, 2007, BIOCHEM BIOPH RES CO, V364, P276, DOI 10.1016/j.bbrc.2007.09.131; Park KT, 2005, MOL PHARMACOL, V67, P612, DOI 10.1124/mol.104.005223; Park S, 2004, J BIOCHEM MOL TOXIC, V18, P322, DOI 10.1002/jbt.20040; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Porter W, 2001, J MOL ENDOCRINOL, V26, P31, DOI 10.1677/jme.0.0260031; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; QUINTANA FJ, 2008, NATURE; Ray SS, 2004, J BIOL CHEM, V279, P27187, DOI 10.1074/jbc.M402771200; Reen RK, 2002, ARCH BIOCHEM BIOPHYS, V408, P93, DOI 10.1016/S0003-9861(02)00518-0; Reiners JJ, 1999, CARCINOGENESIS, V20, P1561, DOI 10.1093/carcin/20.8.1561; Robles R, 2000, ENDOCRINOLOGY, V141, P450, DOI 10.1210/en.141.1.450; Roy NK, 2006, ENVIRON TOXICOL CHEM, V25, P560, DOI 10.1897/05-347R.1; SADHU DN, 1993, ARCH BIOCHEM BIOPHYS, V300, P124, DOI 10.1006/abbi.1993.1017; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Singh SS, 1996, ARCH BIOCHEM BIOPHYS, V329, P47, DOI 10.1006/abbi.1996.0190; Sogawa K, 2004, BIOCHEM BIOPH RES CO, V318, P746, DOI 10.1016/j.bbrc.2004.04.090; Soneda S, 2005, ENDOCR J, V52, P83, DOI 10.1507/endocrj.52.83; Thackaberry EA, 2005, TOXICOL SCI, V88, P231, DOI 10.1093/toxsci/kfi301; Tian Y, 1998, J STEROID BIOCHEM, V67, P17, DOI 10.1016/S0960-0760(98)00067-3; Tiido T, 2007, MOL HUM REPROD, V13, P223, DOI 10.1093/molehr/gal114; Trombino AF, 2000, BREAST CANCER RES TR, V63, P117, DOI 10.1023/A:1006443104670; Tsuchiya M, 2005, FERTIL STERIL, V84, P454, DOI 10.1016/j.fertnstert.2005.01.130; Tsuchiya Y, 2003, TOXICOL SCI, V72, P253, DOI 10.1093/toxsci/kfg022; VELDHOEN M, 2008, NATURE; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Walisser JA, 2004, P NATL ACAD SCI USA, V101, P16677, DOI 10.1073/pnas.0404379101; Wang F, 2001, MOL CELL ENDOCRINOL, V172, P91, DOI 10.1016/S0303-7207(00)00379-8; Watanabe M, 2004, FERTIL STERIL, V82, P1067, DOI 10.1016/j/fernstart.2004.06.027; Watanabe T, 2001, J HUM GENET, V46, P342, DOI 10.1007/s100380170070; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; Wu R, 2007, J PHARMACOL EXP THER, V320, P448, DOI 10.1124/jpet.106.111773; Yamamoto J, 2004, LIFE SCI, V74, P1039, DOI 10.1016/S0024-3205(03)00970-6; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yang XH, 2008, J CELL BIOCHEM, V104, P402, DOI 10.1002/jcb.21630; Zimmermann AL, 2008, TOXICOL SCI, V104, P124, DOI 10.1093/toxsci/kfn066; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	114	87	89	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	FEB 15	2009	77	4			SI		485	497		10.1016/j.bcp.2008.09.016				13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	409TQ	WOS:000263529100003	18848529	Green Accepted			2019-08-20	J	Robey, RB; Hay, N				Robey, R. Brooks; Hay, Nissim			Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis	SEMINARS IN CANCER BIOLOGY			English	Review						Energy metabolism; Glycolysis; Oxygen consumption; Oxidative phosphorylation; Cancer	PERMEABILITY TRANSITION PORE; THREONINE PROTEIN-KINASE; CYTOCHROME-C RELEASE; ATP-CITRATE LYASE; HEXOKINASE-II; CELL-GROWTH; MITOCHONDRIAL HEXOKINASES; SIGNALING PATHWAY; INDUCED APOPTOSIS; MOLECULAR-CLONING	The serine/threonine kinase Akt - also known as protein kinase B (PKB) - has emerged as one of the most frequently activated protein kinases in human cancer. In fact, most, if not all, tumors ultimately find a way to activate this important kinase. As such, Akt activation constitutes a hallmark of most cancer cells, and such ubiquity presumably connotes important roles in tumor genesis and/or progression. Likewise, the hypermetabolic nature of cancer cells and their increased reliance on "aerobic glycolysis", as originally described by Otto Warburg and colleagues, are considered metabolic hallmarks of cancer cells. In this review, we address the specific contributions of Akt activation to the signature metabolic features of cancer cells, including the so-called "Warburg effect". Published by Elsevier Ltd.	[Robey, R. Brooks] Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; [Robey, R. Brooks] Dartmouth Med Sch, Dept Physiol, Hanover, NH USA; [Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA	Robey, RB (reprint author), WRJVA R&D Svc 151, 215 N Main St, White River Jct, VT 05009 USA.	R.Brooks.Robey@Dartmouth.edu; nhay@uic.edu	Robey, R. Brooks/J-7099-2013	Robey, R. Brooks/0000-0001-5059-3965	United States Department of Veterans Affairs; American Heart Association; Hitchcock Foundation; National Institutes of Health	Dr. Robey is an Established Investigator of the American Heart Association. His laboratory is supported by the United States Department of Veterans Affairs, the American Heart Association, and the Hitchcock Foundation. Dr. Hay's laboratory is supported by the National Institutes of Health.	ADAMS V, 1989, BIOCHIM BIOPHYS ACTA, V981, P213, DOI 10.1016/0005-2736(89)90031-X; ARORA KK, 1988, J BIOL CHEM, V263, P17422; AUBERTFOUCHER E, 1984, ARCH BIOCHEM BIOPHYS, V232, P391, DOI 10.1016/0003-9861(84)90554-X; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BELTRANDELRIO H, 1992, ARCH BIOCHEM BIOPHYS, V299, P116, DOI 10.1016/0003-9861(92)90252-R; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Irwin DM, 2008, COMP BIOCHEM PHYS D, V3, P96, DOI 10.1016/j.cbd.2007.11.002; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; PASTEUR M, 1861, EXPERIENCES VILLES N, P1260; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Semenza G. L., 2007, SCI STKE, V2007, pcm8, DOI DOI 10.1126/STKE.4072007CM8; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Smit J, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-4; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; WARBURG O, 1930, METABOLISM TUMOURS B; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	66	291	311	1	46	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1044-579X			SEMIN CANCER BIOL	Semin. Cancer Biol.	FEB	2009	19	1					25	31		10.1016/j.semcancer.2008.11.010				7	Oncology	Oncology	425AF	WOS:000264608700005	19130886	Green Accepted	Y	N	2019-08-20	J	Hou, Z; Romero, R; Uddin, M; Than, NG; Wildman, DE				Hou, Zhuocheng; Romero, Roberto; Uddin, Monica; Than, Nandor Gabor; Wildman, Derek E.			Adaptive history of single copy genes highly expressed in the term human placenta	GENOMICS			English	Article						Evolution; Positive selection; Gene expression; Eutheria; Mouse gene phenotypes; Pregnancy; Comparative genomics	PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; EUTHERIAN MAMMALS; EVOLUTION; TROPHOBLAST; MOUSE; PREGNANCY; DATABASE; PRETERM	The chorioallantoic placenta is a shared derived feature of "placental" mammals essential for the success of eutherian reproduction. Identifying the genes involved in the emergence of the placenta may provide clues for understanding the biology of this organ. Here we identify among 4960 single copy genes in mammals, 222 that show high expression levels in human placentas at term. Further, we present evidence that 94 of these 222 genes evolved adaptively during human evolutionary history since the time of the last common ancestor of eutherian mammals. Remarkably, the majority of positive selection occurred on the eutherian stem lineage suggesting that ancient adaptations have been retained in the human placenta. Of these positively selected genes, 28 have been shown to play a role in human pregnancy and placental biology, and at least 26 have important pregnancy-related phenotypes in mice. Adaptations in genes highly expressed in human placenta are attractive candidates for functional and clinical studies. Published by Elsevier Inc.	[Hou, Zhuocheng; Romero, Roberto; Than, Nandor Gabor; Wildman, Derek E.] Wayne State Univ, Perinatol Res Branch, NICHD, NIH,DHHS, Detroit, MI 48201 USA; [Hou, Zhuocheng; Romero, Roberto; Uddin, Monica; Wildman, Derek E.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Wildman, Derek E.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Than, Nandor Gabor] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1088 Budapest, Hungary; [Hou, Zhuocheng] China Agr Univ, Dept Anim Genet, Beijing 100094, Peoples R China	Romero, R (reprint author), Wayne State Univ, Perinatol Res Branch, NICHD, NIH,DHHS,Hutzel Womens Hosp, 3990 John R, Detroit, MI 48201 USA.	prbchiefstaff@med.wayne.edu; dwildman@med.wayne.edu	Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	Eunice Kennedy Shriver National Institute of Child Health; Human Development/NIH/DHHS	This research was supported in part by the Intramural Research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH/DHHS. We thank Morris Goodman (Wayne State University) for insightful comments on a draft of this manuscript, and we acknowledge Munirul Islam (Wayne State University) for computational assistance. We thank two anonymous reviewer's for their valuable comments.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Asher Robert J., 2005, P50; Benirschke K, 2000, PATHOLOGY HUMAN PLAC; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CHEN CY, 2008, HUMAN PROGESTERONE R, P637; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Elliot MG, 2006, AM NAT, V168, P114, DOI 10.1086/505162; FURUHASHI N, 1994, GYNECOL OBSTET INVES, V37, P250, DOI 10.1159/000292571; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hughes AL, 2000, P NATL ACAD SCI USA, V97, P3319, DOI 10.1073/pnas.050002797; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; KAO LC, 1988, DEV BIOL, V130, P693, DOI 10.1016/0012-1606(88)90361-2; Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; KUSAKABE K, 2007, FERTIL STERIL, V90, P1451; Laigaard J, 2005, OBSTET GYNECOL, V106, P144, DOI 10.1097/01.AOG.0000165829.65319.65; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; LIAO BY, 2008, P NATL ACAD SCI US; LILLEGRAVEN JA, 1975, EVOLUTION, V29, P707, DOI 10.1111/j.1558-5646.1975.tb00865.x; Liu G, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-5; LUCKETT WP, 1974, REPROD BIOL PRIMATES, P142; Mazaki-Tovi S, 2007, SEMIN PERINATOL, V31, P142, DOI 10.1053/j.semperi.2007.04.001; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Micheloud D, 2007, ALLERGOL IMMUNOPATH, V35, P90, DOI 10.1157/13106775; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mossman HW, 1987, VERTEBRATE FETAL MEM; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 1998, GENETICS, V148, P929; Pardi G, 2002, PLACENTA, V23, pS136, DOI 10.1053/plac.2002.0802; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; RAWN SM, 2008, ANNU REV CELL DEV BI, V124, P159; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sanchez-Carbayo M, 2003, AM J PATHOL, V162, P609, DOI 10.1016/S0002-9440(10)63854-0; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spencer K, 2007, J MATERN-FETAL NEO M, V20, P645, DOI 10.1080/14767050701483389; Springer MS, 2007, SYSTEMATIC BIOL, V56, P673, DOI 10.1080/10635150701491149; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki Y, 2004, MOL BIOL EVOL, V21, P914, DOI 10.1093/molbev/msh098; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UDDIN M, 2008, DISTINCT GENOMIC SIG, P3215; Vogel P, 2005, PLACENTA, V26, P591, DOI 10.1016/j.placenta.2004.11.005; Wang XX, 2007, HUM MOL GENET, V16, P2053, DOI 10.1093/hmg/ddm153; Wells M, 2007, PATHOLOGY, V39, P88, DOI 10.1080/00313020601137367; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	63	19	19	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	JAN	2009	93	1					33	41		10.1016/j.ygeno.2008.09.005				9	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	394ZP	WOS:000262492000008	18848617	Green Accepted, Bronze			2019-08-20	